Investors Should Take Note Of Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Inc (AXSM) concluded trading on Thursday at a closing price of $79.80, with 0.49 million shares of worth about $38.91 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.42% during that period and on March 28, 2024 the price saw a gain of about 0.80%. Currently the company’s common shares owned by public are about 47.35M shares, out of which, 38.78M shares are available for trading.

Stock saw a price change of -1.31% in past 5 days and over the past one month there was a price change of -3.80%. Year-to-date (YTD), AXSM shares are showing a performance of 0.26% which increased to 29.74% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $55.02 but also hit the highest price of $98.40 during that period. The average intraday trading volume for Axsome Therapeutics Inc shares is 766.75K. The stock is currently trading 5.33% above its 20-day simple moving average (SMA20), while that difference is down -4.95% for SMA50 and it goes to 5.67% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Axsome Therapeutics Inc (NASDAQ: AXSM) currently have 47.35M outstanding shares and institutions hold larger chunk of about 80.88% of that.

The stock has a current market capitalization of $3.78B and its 3Y-monthly beta is at 1.12. It has posted earnings per share of -$5.20 in the same period. It has Quick Ratio of 3.52 while making debt-to-equity ratio of 0.98. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AXSM, volatility over the week remained 5.55% while standing at 5.12% over the month.

Analysts are in expectations that Axsome Therapeutics Inc (AXSM) stock would likely to be making an EPS of -$1.2 in the current quarter, while forecast for next quarter EPS is -$1.03 and it is $0.99 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.39 which is -$0.98 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.26 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 30.10% while it is estimated to increase by 120.54% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Robert W. Baird on March 19, 2024 offering an Outperform rating for the stock and assigned a target price of $108 to it. Coverage by UBS stated Axsome Therapeutics Inc (AXSM) stock as a Buy in their note to investors on February 06, 2024, suggesting a price target of $111 for the stock. On January 25, 2024, RBC Capital Mkts Initiated their recommendations, while on December 13, 2023, Citigroup Initiated their ratings for the stock with a price target of $125. Stock get a Neutral rating from BofA Securities on August 08, 2023.

Most Popular

Related Posts